 | | FBE | | 表記: | (3E)-5-aminopent-3-enoic acid | | 組成式: | C5 H9 N O2 | | SMILES: | O=C(O)C/C=C/CN | | InChi: | InChI=1S/C5H9NO2/c6-4-2-1-3-5(7)8/h1-2H,3-4,6H2,(H,7,8)/b2-1+ | | 定義日: | 1999-07-08 | | 最終更新日: | 2024-09-27 | | 識別子（ID）: | (3E)-5-aminopent-3-enoic acid |
|
 | | FBQ | | 表記: | 1-[3-({[(4-AMINO-5-FLUORO-2-METHYLQUINOLIN-3-YL)METHYL]THIO}METHYL)PHENYL]-2,2,2-TRIFLUOROETHANE-1,1-DIOL | | 組成式: | C20 H18 F4 N2 O2 S | | SMILES: | FC(F)(F)C(O)(O)c1cccc(c1)CSCc2c(c3c(F)cccc3nc2C)N | | InChi: | InChI=1S/C20H18F4N2O2S/c1-11-14(18(25)17-15(21)6-3-7-16(17)26-11)10-29-9-12-4-2-5-13(8-12)19(27,28)20(22,23)24/h2-8,27-28H,9-10H2,1H3,(H2,25,26) | | 別名: | 4-AMINO-5-FLUORO-2-METHYL-3-(3-TRIFLUOROACETYLBENZYLTHIOMETHYL)QUINOLINE | | 定義日: | 2001-04-24 | | 最終更新日: | 2024-09-27 | | 識別子（ID）: | 1-[3-({[(4-amino-5-fluoro-2-methylquinolin-3-yl)methyl]sulfanyl}methyl)phenyl]-2,2,2-trifluoroethane-1,1-diol |
|
 | | FC0 | | 表記: | N-CARBOXY-L-PHENYLALANINE | | 組成式: | C10 H11 N O4 | | SMILES: | O=C(O)C(NC(=O)O)Cc1ccccc1 | | InChi: | InChI=1S/C10H11NO4/c12-9(13)8(11-10(14)15)6-7-4-2-1-3-5-7/h1-5,8,11H,6H2,(H,12,13)(H,14,15)/t8-/m0/s1 | | 定義日: | 2010-05-11 | | 最終更新日: | 2024-09-27 | | 識別子（ID）: | N-carboxy-L-phenylalanine |
|
 | | FCG | | 表記: | (N5,C4A)-(ALPHA-HYDROXY-PROPANO)-3,4,4A,5-TETRAHYDRO-FLAVIN-ADENINE DINUCLEOTIDE | | 組成式: | C30 H43 N9 O16 P2 | | SMILES: | O=C2NC(O)C73N(c1cc(c(cc1N(C3N2)CC(O)C(O)C(O)COP(=O)(O)OP(=O)(O)OCC6OC(n5cnc4c(ncnc45)N)C(O)C6O)C)C)C(O)CC7 | | InChi: | InChI=1S/C30H43N9O16P2/c1-12-5-14-15(6-13(12)2)39-19(42)3-4-30(39)27(35-29(47)36-28(30)46)37(14)7-16(40)21(43)17(41)8-52-56(48,49)55-57(50,51)53-9-18-22(44)23(45)26(54-18)38-11-34-20-24(31)32-10-33-25(20)38/h5-6,10-11,16-19,21-23,26-28,40-46H,3-4,7-9H2,1-2H3,(H,48,49)(H,50,51)(H2,31,32,33)(H2,35,36,47)/t16-,17+,18+,19+,21-,22+,23+,26+,27-,28+,30-/m0/s1 | | 定義日: | 2006-01-05 | | 最終更新日: | 2024-09-27 | | 識別子（ID）: | [(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl (2R,3S,4S)-5-[(1R,3aS,4R,7aS)-1,4-dihydroxy-10,11-dimethyl-6-oxo-2,3,5,6,7,7a-hexahydro-1H-benzo[g]pyrrolo[2,1-e]pteridin-8(4H)-yl]-2,3,4-trihydroxypentyl dihydrogen diphosphate (non-preferred name) |
|
 | | FCL | | 表記: | 3-CHLORO-L-PHENYLALANINE | | 組成式: | C9 H10 Cl N O2 | | SMILES: | Clc1cc(ccc1)CC(C(=O)O)N | | InChi: | InChI=1S/C9H10ClNO2/c10-7-3-1-2-6(4-7)5-8(11)9(12)13/h1-4,8H,5,11H2,(H,12,13)/t8-/m0/s1 | | 定義日: | 2003-07-31 | | 最終更新日: | 2024-09-27 | | 識別子（ID）: | 3-chloro-L-phenylalanine |
|
 | | FDA | | 表記: | DIHYDROFLAVINE-ADENINE DINUCLEOTIDE | | 組成式: | C27 H35 N9 O15 P2 | | SMILES: | O=C3C=2Nc1cc(c(cc1N(C=2NC(=O)N3)CC(O)C(O)C(O)COP(=O)(O)OP(=O)(O)OCC6OC(n5cnc4c(ncnc45)N)C(O)C6O)C)C | | InChi: | InChI=1S/C27H35N9O15P2/c1-10-3-12-13(4-11(10)2)35(24-18(32-12)25(42)34-27(43)33-24)5-14(37)19(39)15(38)6-48-52(44,45)51-53(46,47)49-7-16-20(40)21(41)26(50-16)36-9-31-17-22(28)29-8-30-23(17)36/h3-4,8-9,14-16,19-21,26,32,37-41H,5-7H2,1-2H3,(H,44,45)(H,46,47)(H2,28,29,30)(H2,33,34,42,43)/t14-,15+,16+,19-,20+,21+,26+/m0/s1 | | 定義日: | 1999-07-08 | | 最終更新日: | 2024-09-27 | | 識別子（ID）: | [(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl (2R,3S,4S)-5-(7,8-dimethyl-2,4-dioxo-1,3,4,5-tetrahydrobenzo[g]pteridin-10(2H)-yl)-2,3,4-trihydroxypentyl dihydrogen diphosphate (non-preferred name) |
|
 | | HS8 | | 表記: | 3-(1-sulfo-1H-imidazol-3-ium-4-yl)-L-alanine | | 組成式: | C6 H10 N3 O5 S | | SMILES: | O=S(=O)(O)n1cc([nH+]c1)CC(C(=O)O)N | | InChi: | InChI=1S/C6H9N3O5S/c7-5(6(10)11)1-4-2-9(3-8-4)15(12,13)14/h2-3,5H,1,7H2,(H,10,11)(H,12,13,14)/p+1/t5-/m0/s1 | | 定義日: | 2008-11-13 | | 最終更新日: | 2024-09-27 | | 識別子（ID）: | 3-(1-sulfo-1H-imidazol-3-ium-4-yl)-L-alanine |
|
 | | HS9 | | 表記: | N-ALPHA-METHYL-L-HISTIDINAMIDE | | 組成式: | C7 H12 N4 O | | SMILES: | O=C(N)C(NC)Cc1ncnc1 | | InChi: | InChI=1S/C7H12N4O/c1-9-6(7(8)12)2-5-3-10-4-11-5/h3-4,6,9H,2H2,1H3,(H2,8,12)(H,10,11)/t6-/m0/s1 | | 別名: | N-METHYL-L-HISTIDINAMIDE | | 定義日: | 2009-09-02 | | 最終更新日: | 2024-09-27 | | 識別子（ID）: | Nalpha-methyl-L-histidinamide |
|
 | | HSE | | 表記: | L-HOMOSERINE | | 組成式: | C4 H9 N O3 | | SMILES: | O=C(O)C(N)CCO | | InChi: | InChI=1S/C4H9NO3/c5-3(1-2-6)4(7)8/h3,6H,1-2,5H2,(H,7,8)/t3-/m0/s1 | | 定義日: | 2000-02-02 | | 最終更新日: | 2024-09-27 | | 識別子（ID）: | L-homoserine |
|
 | | HSF | | 表記: | 1-HEXADECYLSULFONYL FLUORIDE | | 組成式: | C16 H33 F O2 S | | SMILES: | FS(=O)(=O)CCCCCCCCCCCCCCCC | | InChi: | InChI=1S/C16H33FO2S/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-20(17,18)19/h2-16H2,1H3 | | 定義日: | 2000-05-10 | | 最終更新日: | 2024-09-27 | | 識別子（ID）: | hexadecane-1-sulfonyl fluoride |
|
 | | HSL | | 表記: | HOMOSERINE LACTONE | | 組成式: | C4 H7 N O2 | | SMILES: | O=C1OCCC1N | | InChi: | InChI=1S/C4H7NO2/c5-3-1-2-7-4(3)6/h3H,1-2,5H2/t3-/m0/s1 | | 定義日: | 2001-11-02 | | 最終更新日: | 2024-09-27 | | 識別子（ID）: | (3S)-3-aminodihydrofuran-2(3H)-one |
|
 | | HSO | | 表記: | L-histidinol | | 組成式: | C6 H12 N3 O | | SMILES: | NC(CO)Cc1[nH+]cnc1 | | InChi: | InChI=1S/C6H11N3O/c7-5(3-10)1-6-2-8-4-9-6/h2,4-5,10H,1,3,7H2,(H,8,9)/p+1/t5-/m0/s1 | | 定義日: | 1999-07-08 | | 最終更新日: | 2024-09-27 | | 識別子（ID）: | 4-[(2S)-2-amino-3-hydroxypropyl]-1H-imidazol-3-ium |
|
 | | HSQ | | 表記: | 2-acetylamino-2-deoxy-alpha-L-idopyranose | | 組成式: | C8 H15 N O6 | | SMILES: | O=C(NC1C(O)C(O)C(OC1O)CO)C | | InChi: | InChI=1S/C8H15NO6/c1-3(11)9-5-7(13)6(12)4(2-10)15-8(5)14/h4-8,10,12-14H,2H2,1H3,(H,9,11)/t4-,5+,6+,7+,8+/m0/s1 | | 別名: | N-acetyl-alpha-L-idosamine | | 定義日: | 2009-01-16 | | 最終更新日: | 2024-09-27 | | 識別子（ID）: | 2-(acetylamino)-2-deoxy-alpha-L-idopyranose |
|
 | | HSV | | 表記: | L-histidinal | | 組成式: | C6 H10 N3 O | | SMILES: | NC(C=O)Cc1[nH+]cnc1 | | InChi: | InChI=1S/C6H9N3O/c7-5(3-10)1-6-2-8-4-9-6/h2-5H,1,7H2,(H,8,9)/p+1/t5-/m0/s1 | | 定義日: | 2015-06-17 | | 最終更新日: | 2024-09-27 | | 識別子（ID）: | 4-[(2S)-2-amino-3-oxopropyl]-1H-imidazol-3-ium |
|
 | | HSX | | 表記: | 5-O-phosphono-alpha-D-ribofuranose | | 組成式: | C5 H11 O8 P | | SMILES: | O=P(O)(O)OCC1OC(O)C(O)C1O | | InChi: | InChI=1S/C5H11O8P/c6-3-2(1-12-14(9,10)11)13-5(8)4(3)7/h2-8H,1H2,(H2,9,10,11)/t2-,3-,4-,5+/m1/s1 | | 別名: | 5-O-phosphono-alpha-D-ribose | | 定義日: | 2009-01-16 | | 最終更新日: | 2024-09-27 | | 識別子（ID）: | 5-O-phosphono-alpha-D-ribofuranose |
|
 | | HSY | | 表記: | alpha-L-xylopyranose | | 組成式: | C5 H10 O5 | | SMILES: | OC1C(O)COC(O)C1O | | InChi: | InChI=1S/C5H10O5/c6-2-1-10-5(9)4(8)3(2)7/h2-9H,1H2/t2-,3+,4-,5+/m0/s1 | | 別名: | alpha-L-xylose | | 定義日: | 2009-01-16 | | 最終更新日: | 2024-09-27 | | 識別子（ID）: | alpha-L-xylopyranose |
|
 | | HT0 | | 表記: | (4R,5R)-5-(4-hydroxyphenyl)-2-oxo-1,3-oxazolidine-4-carboxylic acid | | 組成式: | C10 H9 N O5 | | SMILES: | O=C(O)C1NC(=O)OC1c1ccc(O)cc1 | | InChi: | InChI=1S/C10H9NO5/c12-6-3-1-5(2-4-6)8-7(9(13)14)11-10(15)16-8/h1-4,7-8,12H,(H,11,15)(H,13,14)/t7-,8-/m1/s1 | | 定義日: | 2021-03-10 | | 最終更新日: | 2024-09-27 | | 公開日: | 2022-12-07 | | 識別子（ID）: | (4R,5R)-5-(4-hydroxyphenyl)-2-oxo-1,3-oxazolidine-4-carboxylic acid |
|
 | | HT7 | | 表記: | (3S)-3-AMINO-4-(1H-INDOL-3-YL)BUTANOIC ACID | | 組成式: | C12 H14 N2 O2 | | SMILES: | O=C(O)CC(N)Cc2c1ccccc1nc2 | | InChi: | InChI=1S/C12H14N2O2/c13-9(6-12(15)16)5-8-7-14-11-4-2-1-3-10(8)11/h1-4,7,9,14H,5-6,13H2,(H,15,16)/t9-/m0/s1 | | 別名: | BETA-HOMOTRYPTOPHAN | | 定義日: | 2011-05-18 | | 最終更新日: | 2024-09-27 | | 識別子（ID）: | (3S)-3-amino-4-(1H-indol-3-yl)butanoic acid |
|
 | | HTI | | 表記: | (4S)-4-{[(2S)-2-AMINO-3-OXOPROPYL]SULFANYL}-L-HOMOSERINE | | 組成式: | C7 H14 N2 O5 S | | SMILES: | O=C(O)C(N)CSC(O)CC(C(=O)O)N | | InChi: | InChI=1S/C7H14N2O5S/c8-3(6(11)12)1-5(10)15-2-4(9)7(13)14/h3-5,10H,1-2,8-9H2,(H,11,12)(H,13,14)/t3-,4-,5+/m0/s1 | | 定義日: | 2003-03-04 | | 最終更新日: | 2024-09-27 | | 識別子（ID）: | (4R)-4-{[(2R)-2-amino-2-carboxyethyl]sulfanyl}-L-homoserine |
|
 | | HTN | | 表記: | (3R)-3-hydroxy-N-methyl-D-asparagine | | 組成式: | C5 H10 N2 O4 | | SMILES: | O=C(NC)C(O)C(C(=O)O)N | | InChi: | InChI=1S/C5H10N2O4/c1-7-4(9)3(8)2(6)5(10)11/h2-3,8H,6H2,1H3,(H,7,9)(H,10,11)/t2-,3-/m1/s1 | | 定義日: | 2008-06-03 | | 最終更新日: | 2024-09-27 | | 識別子（ID）: | (3R)-3-hydroxy-N-methyl-D-asparagine |
|
 | | HTR | | 表記: | BETA-HYDROXYTRYPTOPHANE | | 組成式: | C11 H12 N2 O3 | | SMILES: | O=C(O)C(N)C(O)c2c1ccccc1nc2 | | InChi: | InChI=1S/C11H12N2O3/c12-9(11(15)16)10(14)7-5-13-8-4-2-1-3-6(7)8/h1-5,9-10,13-14H,12H2,(H,15,16)/t9-,10-/m0/s1 | | 定義日: | 1999-07-08 | | 最終更新日: | 2024-09-27 | | 識別子（ID）: | (betaS)-beta-hydroxy-L-tryptophan |
|
 | | HTS | | 表記: | 2-MERCAPTOPHENOL | | 組成式: | C6 H6 O S | | SMILES: | c1c(c(ccc1)S)O | | InChi: | InChI=1S/C6H6OS/c7-5-3-1-2-4-6(5)8/h1-4,7-8H | | 別名: | 2-HYDROXYTHIOPHENOL | | 定義日: | 2007-02-27 | | 最終更新日: | 2024-09-27 | | 識別子（ID）: | 2-sulfanylphenol |
|
 | | HTU | | 表記: | 4-sulfanylphenol | | 組成式: | C6 H6 O S | | SMILES: | Oc1ccc(S)cc1 | | InChi: | InChI=1S/C6H6OS/c7-5-1-3-6(8)4-2-5/h1-4,7-8H | | 定義日: | 2012-02-17 | | 最終更新日: | 2024-09-27 | | 公開日: | 2024-03-27 | | 識別子（ID）: | 4-sulfanylphenol |
|
 | | HTY | | 表記: | (betaR)-beta-hydroxy-D-tyrosine | | 組成式: | C9 H11 N O4 | | SMILES: | O=C(O)C(N)C(O)c1ccc(O)cc1 | | InChi: | InChI=1S/C9H11NO4/c10-7(9(13)14)8(12)5-1-3-6(11)4-2-5/h1-4,7-8,11-12H,10H2,(H,13,14)/t7-,8-/m1/s1 | | 定義日: | 2002-09-02 | | 最終更新日: | 2024-09-27 | | 識別子（ID）: | (betaR)-beta-hydroxy-D-tyrosine |
|
 | | HU1 | | 表記: | TERT-BUTYL {(1S)-2-[(1R,2S,5S)-2-({[(1S)-3-AMINO-1-(CYCLOBUTYLMETHYL)-2,3-DIOXOPROPYL]AMINO}CARBONYL)-6,6-DIMETHYL-3-AZABICYCLO[3.1.0]HEX-3-YL]-1-CYCLOHEXYL-2-OXOETHYL}CARBAMATE | | 組成式: | C29 H46 N4 O6 | | SMILES: | O=C(N3C(C(=O)NC(C(=O)C(=O)N)CC1CCC1)C2C(C)(C2C3)C)C(NC(=O)OC(C)(C)C)C4CCCCC4 | | InChi: | InChI=1S/C29H46N4O6/c1-28(2,3)39-27(38)32-21(17-12-7-6-8-13-17)26(37)33-15-18-20(29(18,4)5)22(33)25(36)31-19(23(34)24(30)35)14-16-10-9-11-16/h16-22H,6-15H2,1-5H3,(H2,30,35)(H,31,36)(H,32,38)/t18-,19-,20-,21-,22-/m0/s1 | | 別名: | Ketoamide Inhibitor SCH491762, bound form | | 定義日: | 2007-01-08 | | 最終更新日: | 2024-09-27 | | 識別子（ID）: | tert-butyl {(1S)-2-[(1R,2S,5S)-2-{[(2S)-4-amino-1-cyclobutyl-3,4-dioxobutan-2-yl]carbamoyl}-6,6-dimethyl-3-azabicyclo[3.1.0]hex-3-yl]-1-cyclohexyl-2-oxoethyl}carbamate |
|
